Please login to the form below

Not currently logged in
Email:
Password:

GSK public-private partnership CTTV names director

Centre for Therapeutic Target Validation launched last year
Dr Jeffrey Barrett

The Centre for Therapeutic Target Validation (CTTV), the product of a GSK public and private partnership, has formally appointed Dr Jeffrey Barrett as the founding director.

The CTTV, produced from a partnership between GSK, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute, launched a year ago and uses genome-scale experiments and analysis to look at therapeutic targets and research into treatments.

Treatments areas focused on by the partnership include cancer, inflammatory bowel disease and respiratory disease, with a commitment to share its data openly with the scientific community.

Barrett has been involved in the CTTV since its creation in 2014 and will start in his new role as director from May 1.

Commenting on the CTTV, Barrett said: “We are applying methods and technologies available on the Wellcome Genome Campus to help pharmaceutical researchers focus their detailed studies of biological mechanisms and improve their methods for designing effective medicines.

“The CTTV blends the pharmaceutical industry's sense of enterprise and motion, an academic style that gives questions the time and patience they need, and public data services to integrate many layers of knowledge.”

Barrett is currently group leader at the Wellcome Trust Sanger Institute, where his research group analyses genomic variation in thousands of individuals to identify genetic risk factors for disease.

Dr Patrick Vallance, president of pharmaceuticals R&D at GSK, added: “Jeff brings to this key role scientific vision and profound expertise in human genetics and bioinformatics.

“His scientific skills, vision and leadership are what we need to continue to advance the work we do within the centre.”

Article by
Kirstie Pickering

3rd March 2015

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics